People
Duane Selby
Partner & Managing Director
Los Angeles
Mid-market medical device companies are grappling with underperformance, driven in part by over-diversified portfolios and fragmented management focus. As these companies seek profitable growth and greater shareholder value, many are realizing the need to re-center on their core business. A well-executed divestiture of non-core assets can unlock margin expansion, sharpen strategic focus, and revitalize investment potential. However, achieving success requires more than just deal execution—it demands disciplined planning and targeted transformation before and after the transaction.
Read our perspectives below or download the report here.
